S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer
A Randomized Trial Assessing the Effects of Exercise on Patients With Locally Advanced Lung Cancer Undergoing Curative Intent Combined Modality Therapy
RATIONALE: Pulmonary rehabilitation education and exercise training may improve physical function and quality of life in patients who are receiving treatment for lung cancer.
PURPOSE: This randomized clinical trial is studying pulmonary rehabilitation education and exercise training to see how well they work compared to exercise training alone in improving physical function and quality of life in patients who are undergoing chemotherapy and radiation therapy for locally advanced lung cancer.
調査の概要
詳細な説明
OBJECTIVES:
- Compare improvement in physiologic function, in terms of exercise tolerance, in patients with inoperable locally advanced lung cancer undergoing chemoradiotherapy and randomized to pulmonary rehabilitation comprising education with vs without supervised exercise training.
- Compare the health-related quality of life, in terms of multidimensional functioning and patient perception of respiratory difficulties, in patients undergoing these pulmonary rehabilitation interventions.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to Zubrod performance status (0-1 vs 2); FEV_1 (≥ 70% of predicted vs < 70% of predicted); and smoking status* (never smoked or former smoker vs current smoker). Approximately 20 weeks into treatment on SWOG-S0023, patients are randomized to 1 of 2 intervention arms.
NOTE: * Never smoked is defined as < 100 cigarettes in a lifetime and former smoker is defined as no smoking for ≥ 1 year.
- Arm I: Patients participate in a supervised structured exercise program (i.e., walking on a treadmill OR using a stationary exercise bicycle) 3 times a week for 12 weeks. Patients also receive educational materials on how to improve breathing and conserve energy.
- Arm II: Patients receive educational materials as in arm I. In both arms, patients undergo exercise testing using 6-minute walks to measure exercise tolerance at initial evaluation (after randomization but prior to intervention), 12 weeks, and then at 6 and 9 months.
In both arms, intervention continues in the absence of disease progression or the development of other medical conditions that would preclude study participation.
Quality of life is assessed at baseline, 12 weeks, and then at 6 and 9 months.
PROJECTED ACCRUAL: A total of 164 patients (82 per treatment arm) will be accrued for this study.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Colorado
-
Fort Collins、Colorado、アメリカ、80524
- Poudre Valley Hospital
-
-
Illinois
-
Decatur、Illinois、アメリカ、62526
- Decatur Memorial Hospital Cancer Care Institute
-
Maywood、Illinois、アメリカ、60153
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
-
Springfield、Illinois、アメリカ、62781-0001
- Regional Cancer Center at Memorial Medical Center
-
-
Kansas
-
Chanute、Kansas、アメリカ、66720
- Cancer Center of Kansas, PA - Chanute
-
Dodge City、Kansas、アメリカ、67801
- Cancer Center of Kansas, PA - Dodge City
-
El Dorado、Kansas、アメリカ、67042
- Cancer Center of Kansas, PA - El Dorado
-
Independence、Kansas、アメリカ、67301
- Cancer Center of Kansas-Independence
-
Kingman、Kansas、アメリカ、67068
- Cancer Center of Kansas, PA - Kingman
-
Liberal、Kansas、アメリカ、67901
- Southwest Medical Center
-
Newton、Kansas、アメリカ、67114
- Cancer Center of Kansas, PA - Newton
-
Parsons、Kansas、アメリカ、67357
- Cancer Center of Kansas, PA - Parsons
-
Pratt、Kansas、アメリカ、67124
- Cancer Center of Kansas, PA - Pratt
-
Salina、Kansas、アメリカ、67042
- Cancer Center of Kansas, PA - Salina
-
Salina、Kansas、アメリカ、67401
- Tammy Walker Cancer Center at Salina Regional Health Center
-
Wellington、Kansas、アメリカ、67152
- Cancer Center of Kansas, PA - Wellington
-
Wichita、Kansas、アメリカ、67208
- Cancer Center of Kansas, PA - Medical Arts Tower
-
Wichita、Kansas、アメリカ、67214
- Cancer Center of Kansas, PA - Wichita
-
Wichita、Kansas、アメリカ、67214
- CCOP - Wichita
-
Wichita、Kansas、アメリカ、67214
- Via Christi Cancer Center at Via Christi Regional Medical Center
-
Wichita、Kansas、アメリカ、67208
- Associates in Womens Health, PA - North Review
-
Winfield、Kansas、アメリカ、67156
- Cancer Center of Kansas, PA - Winfield
-
-
Michigan
-
Detroit、Michigan、アメリカ、48201-1379
- Barbara Ann Karmanos Cancer Institute
-
-
Mississippi
-
Pascagoula、Mississippi、アメリカ、39581
- Regional Cancer Center at Singing River Hospital
-
-
Missouri
-
Springfield、Missouri、アメリカ、65802
- CCOP - Cancer Research for the Ozarks
-
Springfield、Missouri、アメリカ、65804
- St. John's Regional Health Center
-
Springfield、Missouri、アメリカ、65807
- Hulston Cancer Center at Cox Medical Center South
-
-
Montana
-
Billings、Montana、アメリカ、59101
- CCOP - Montana Cancer Consortium
-
Billings、Montana、アメリカ、59101
- Hematology-Oncology Centers of the Northern Rockies - Billings
-
Billings、Montana、アメリカ、59101
- Northern Rockies Radiation Oncology Center
-
Billings、Montana、アメリカ、59101
- St. Vincent Healthcare Cancer Care Services
-
Billings、Montana、アメリカ、59107-7000
- Billings Clinic - Downtown
-
Bozeman、Montana、アメリカ、59715
- Bozeman Deaconess Cancer Center
-
Butte、Montana、アメリカ、59701
- St. James Healthcare Cancer Care
-
Great Falls、Montana、アメリカ、59405
- Great Falls Clinic - Main Facility
-
Great Falls、Montana、アメリカ、59405
-
Great Falls、Montana、アメリカ、59405-5309
- Big Sky Oncology
-
Great Falls、Montana、アメリカ、59405
- Sletten Cancer Institute at Benefis Healthcare
-
Havre、Montana、アメリカ、59501
- Northern Montana Hospital
-
Helena、Montana、アメリカ、59601
- St. Peter's Hospital
-
Kalispell、Montana、アメリカ、59901
- Kalispell Regional Medical Center
-
Kalispell、Montana、アメリカ、59901
- Glacier Oncology, PLLC
-
Kalispell、Montana、アメリカ、59901
- Kalispell Medical Oncology at KRMC
-
Missoula、Montana、アメリカ、59801
- Community Medical Center
-
Missoula、Montana、アメリカ、59804
- Guardian Oncology and Center for Wellness
-
Missoula、Montana、アメリカ、59807-7877
- Montana Cancer Specialists at Montana Cancer Center
-
Missoula、Montana、アメリカ、59807
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
-
-
North Carolina
-
Goldsboro、North Carolina、アメリカ、27534
- Wayne Memorial Hospital, Incorporated
-
-
Washington
-
Bellingham、Washington、アメリカ、98225
- St. Joseph Cancer Center
-
Bremerton、Washington、アメリカ、98310
- Olympic Hematology and Oncology
-
Kennewick、Washington、アメリカ、99336
- Columbia Basin Hematology
-
Seattle、Washington、アメリカ、98104
- Harborview Medical Center
-
Seattle、Washington、アメリカ、98104
- Fred Hutchinson Cancer Research Center
-
Seattle、Washington、アメリカ、98104
- Minor and James Medical, PLLC
-
Seattle、Washington、アメリカ、98112
- Group Health Central Hospital
-
Seattle、Washington、アメリカ、98122-4307
- Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
-
Seattle、Washington、アメリカ、98122
- Polyclinic First Hill
-
Seattle、Washington、アメリカ、98195-6043
- University Cancer Center at University of Washington Medical Center
-
Spokane、Washington、アメリカ、99202
- Cancer Care Northwest - Spokane South
-
-
Wyoming
-
Sheridan、Wyoming、アメリカ、82801
- Welch Cancer Center at Sheridan Memorial Hospital
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
説明
DISEASE CHARACTERISTICS:
Histologically or cytologically confirmed single, primary bronchogenic lung cancer
- Inoperable, locally advanced disease (unresectable stage IIIA OR stage IIIB disease)
The following histologies are eligible:
- Adenocarcinoma
- Large cell carcinoma
- Squamous cell carcinoma
- Non-lobar and non-diffuse bronchoalveolar carcinoma
- Small cell lung cancer
Must have received chemotherapy (platinum based) and radiotherapy for locally advanced unresectable lung cancer
- Must have achieved a complete response, partial response, or stable disease after treatment
PATIENT CHARACTERISTICS:
Age
- Not specified
Performance status
- Zubrod 0-2
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Cardiovascular
- No acute EKG changes, arrhythmia, or other cardiac abnormality that would preclude study participation
- No uncontrolled cardiac disease
- No recent myocardial infarction
Pulmonary
- Any FEV_1 level by pulmonary function testing
Other
- Willing to participate in 12-week long exercise program
- Chemotherapy-induced neuropathy ≤ grade 2
- No uncontrolled diabetes mellitus
- No other medical condition that would preclude study participation
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- See Disease Characteristics
Endocrine therapy
- Not specified
Radiotherapy
- See Disease Characteristics
Surgery
- Not specified
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:12-week exercise program + education
A 12-week supervised exercise program consisting of 3 days a week on a stationary bike or treadmill.
In addition, at the time of enrollment patients are provided educational materials focusing on breathing and energy conservation.
|
|
他の:Education
At the time of enrollment patients are provided educational materials focusing on breathing and energy conservation.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Exercise tolerance
時間枠:Baseline and at 6 months
|
comparison between the control and intervention arms in the percent change in the 6-minute walk distance between baseline and 6 months.
|
Baseline and at 6 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Health-related quality of life
時間枠:Baseline and at 6 months.
|
The difference in total score between pre-study and 6 months for the FACT-L Quality of Life measure.
|
Baseline and at 6 months.
|
協力者と研究者
スポンサー
捜査官
- スタディチェア:Antoinette J. Wozniak, MD、Barbara Ann Karmanos Cancer Institute
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- CDR0000380928
- U10CA012027 (米国 NIH グラント/契約)
- SWOG-S0229
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
肺癌の臨床試験
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Highlight Therapeutics積極的、募集していない平滑筋肉腫 | 悪性末梢神経鞘腫瘍 | 滑膜肉腫 | 未分化多形肉腫 | 骨の未分化高悪性度多形肉腫 | 粘液線維肉腫 | II期の体幹および四肢の軟部肉腫 AJCC v8 | III期の体幹および四肢の軟部肉腫 AJCC v8 | IIIA 期の体幹および四肢の軟部肉腫 AJCC v8 | IIIB 期の体幹および四肢の軟部肉腫 AJCC v8 | 切除可能な軟部肉腫 | 多形性横紋筋肉腫 | 切除可能な脱分化型脂肪肉腫 | 切除可能な未分化多形肉腫 | 軟部組織線維肉腫 | 紡錘細胞肉腫 | ステージ I 後腹膜肉腫 AJCC (American Joint Committee on Cancer) v8 | 体幹および四肢の I 期軟部肉腫 AJCC v8 | ステージ... およびその他の条件アメリカ
教育介入の臨床試験
-
University of MichiganNational Institute on Drug Abuse (NIDA)募集
-
University of PittsburghCenters for Disease Control and Preventionまだ募集していません暴力, ドメスティック | 思春期の暴力 | 暴力、性的 | 暴力、身体的 | 暴力, 偶然ではない | 社会的結束 | 暴力、構造 | コミュニティ内暴力アメリカ
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical Center; Tobacco Related Disease Research Program完了
-
University of Southern CaliforniaNational Institutes of Health (NIH)積極的、募集していない
-
Munich Municipal HospitalTechnical University of Munich; University of Regensburgわからない
-
Massachusetts General HospitalNational Institutes of Health (NIH); Samaritans of Bostonまだ募集していません自殺念慮 | 自殺未遂 | 自殺